glp-1 and glp-2 drugs of GLP-1RAs approved for the treatment of type 2 diabetes. FDA US Food New GLP-1 Guidelines for Type

However, in the late or chronic phase, autophagy becomes impaired due to lysosomal dysfunction and defective autophagosome-lysosome fusion, leading to the accumulation of autophagic vacuoles and the adaptor protein p62/SQSTM1, with a potential shift toward autosis

Michaelidou K, Agelaki S, Mavridis K

Common side effects include nausea, vomiting, and constipation, particularly when first starting the medication

This advanced lipolysis solution, designed for use on both the face and body, targets stubborn fat cells for a noticeable reduction and a more contoured appearance

Today, the evidence base is growing, the results are hard to argue with, and patients across Dubai are discovering why this peptide is rapidly becoming one of the most requested therapies at our clinic